All Pharma News
Disc Reports Topline Results from Ph 2 Study of Bitopertin in Patients with EPP

Disc Reports Topline Results from Ph 2 Study of Bitopertin in Patients with EPP
GLOBENEWSWIRE
01 Apr 2024
Share Share
Disc blames `outsized` placebo response on mixed Pha 2 data rare blood disorder

Disc blames `outsized` placebo response on mixed Pha 2 data rare blood disorder
Amber Tong ENDPTS
01 Apr 2024
Share Share
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results

Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results
GLOBENEWSWIRE
21 Mar 2024
Share Share
Disc Medicine to Participate in the Leerink Partners Biopharma Conference 2024

Disc Medicine to Participate in the Leerink Partners Biopharma Conference 2024
GLOBENEWSWIRE
06 Mar 2024
Share Share
Disc Medicine Expands Leadership Team

Disc Medicine Expands Leadership Team
GLOBENEWSWIRE
26 Feb 2024
Share Share
Disc Medicine Receives FDA Fast Track Designation for DISC-0974

Disc Medicine Receives FDA Fast Track Designation for DISC-0974
GLOBENEWSWIRE
20 Feb 2024
Share Share
Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405

Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405
GLOBENEWSWIRE
09 Feb 2024
Share Share
Disc Medicine Strengthens Leadership Team

Disc Medicine Strengthens Leadership Team
GLOBENEWSWIRE
07 Feb 2024
Share Share
Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GLOBENEWSWIRE
03 Jan 2024
Share Share
Disc Announces Retirement of Brian MacDonald as Chief Innovation Officer

Disc Announces Retirement of Brian MacDonald as Chief Innovation Officer
GLOBENEWSWIRE
20 Dec 2023
Share Share